QR-Code

Harnessing acoustic speech parameters to decipher amyloid status in individuals with mild cognitive impairment

Alzheimer's disease (AD) is a neurodegenerative condition characterized by a gradual decline in cognitive functions. Currently, there are no effective treatments for AD, underscoring the importance of identifying individuals in the preclinical stages of mild cognitive impairment (MCI) to enable earl...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Fernando García-Gutiérrez, Marta Marquié, Nathalia Muñoz, Montserrat Alegret, Amanda Cano, Itziar de Rojas, Pablo García-González, Clàudia Olivé, Raquel Puerta, Adelina Orellana, Laura Montrreal, Vanesa Pytel, Mario Ricciardi, Carla Zaldua, Peru Gabirondo, Wolfram Hinzen, Núria Lleonart, Ainhoa García-Sánchez, Lluís Tárraga, Agustín Ruiz, Mercè Boada, Sergi Valero
Format: Artigo
Sprache:Inglês
Veröffentlicht: Frontiers Media S.A. 2023-09-01
Schriftenreihe:Frontiers in Neuroscience
Schlagworte:
Alzheimer's disease
mild cognitive impairment
early diagnosis
cerebrospinal fluid
biomarkers
machine learning
Online-Zugang:https://www.frontiersin.org/articles/10.3389/fnins.2023.1221401/full
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge